Cell line · CVCL_0511
Raji
Cancer cell line, Homo sapiens. EBV-related Burkitt lymphoma. 182 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. Raji. Cell lines, record CVCL_0511. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0511
On this page
Cell line
As Cellosaurus gives it.
- Name
- Raji
- Accession
- CVCL_0511
- RRID
- RRID:CVCL_0511
- Synonyms
- RAJI, P1-Raji, GM04671
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 11Y
- Category
- Cancer cell line
- Diseases
- EBV-related Burkitt lymphoma (NCIt C27694); Burkitt lymphoma (ORDO Orphanet_543)
- Derived from
- Bone, jaw, maxilla (in situ)
- Cell type
- B-cell
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers182
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Anti-PD-L1 scFv-secreting fifth-generation GD2-CAR T cells enhance antitumor function against GD2-low retinoblastoma. | Mol Ther Nucleic Acids | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A metabolic-oxidative axis contributes to NK cell cryo-vulnerability. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| PARP Inhibitors plus Anlotinib as Bridging Therapy for Armored CAR-T Cells in Ovarian Cancer Enhances Infiltration and Antitumor Efficacy. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Meditope-Enabled Chimeric Antigen Receptors Facilitate Plug-and-Play Control of T Cells. | Cancer Immunol Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting CD24 Activates Macrophages to Reduce Tumor Burden in Preclinical Models of Solid Tumors. | Clin Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A first-in-class bifunctional antibody targeting CD20 and CD37 remodels the immune microenvironment in relapsed or refractory B-cell malignancies. | J Hematol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A high-throughput modular microfluidic platform for versatile functional assays at single-cell level. | Microsyst Nanoeng | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Optimizing Zirconium-89 labeling for chimeric antigen receptor T cell PET imaging by comparing desferrioxamine and oxine. | Sci Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Moderate-Affinity Antibody-Drug Conjugate Targeting B7-H3 Exerts Potent Antitumor Efficacy. | Pharmaceuticals (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The Growth Supporting Role of ZDHHC11 Is Linked to the MEF2B-BCL6 Regulatory Circuit in Burkitt Lymphoma. | Int J Cancer | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 182
See all 182 papersRelatives417
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | Abcam Raji AATF KO | CVCL_B7VS | Cell lines | |
| Derived from it | Abcam Raji ABCB1 KO | CVCL_B7VT | Cell lines | |
| Derived from it | Abcam Raji ABI1 KO | CVCL_D2HQ | Cell lines | |
| Derived from it | Abcam Raji ACAA1 KO | CVCL_D2HR | Cell lines | |
| Derived from it | Abcam Raji ACOT13 KO | CVCL_D2HS | Cell lines | |
| Derived from it | Abcam Raji ACTR3 KO | CVCL_D2HT | Cell lines | |
| Derived from it | Abcam Raji ACVR2B KO | CVCL_D2HU | Cell lines | |
| Derived from it | Abcam Raji ACVRL1 KO | CVCL_D2HV | Cell lines | |
| Derived from it | Abcam Raji ACY1 KO | CVCL_D2HW | Cell lines | |
| Derived from it | Abcam Raji ADD1 KO | CVCL_D2HX | Cell lines |
1 to 10 of 417
See all 417 relativesCell banks22
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CCL-86 | ATCC | |
| ATCC | CRL-7936 | Discontinued | Cellosaurus |
| Abcam | ab271145 | Abcam | |
| Abcam | ab275473 | Abcam | |
| AddexBio | C0003009/4668 | Cellosaurus | |
| BCRC | 60116 | BCRC | |
| BCRJ | 0211 | BCRJ | |
| BEI_Resources | ARP-9944 | BEI_Resources | |
| CCTCC | GDC0191 | Cellosaurus | |
| CLS | 300359 | CLS |
1 to 10 of 22
See all 22 cell banksData dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0511
GET https://conductscience.org/api/cell-lines/v1/CVCL_0511/papers?page=2